Watch: How TJM Labs Reached $25M ARR and 450 Pharmacies with 40% EBITDA (Interview with Jonathan Adly)July 2026 · Jonathan Adly, Founder & CEO
How TJM Labs Reached $25M ARR and 450 Pharmacies with 40% EBITDA (Interview with Jonathan Adly)
- Revenue$25MWatch at 12:21
- Revenue$15MWatch at 12:50
- ProfitableYesWatch at 16:52
- EBITDA margin40%Watch at 17:36
- Customers450Watch at 11:29
- Price per seat$45KWatch at 7:47
- +1 more